General Information of Drug Transporter (DT)
DT ID DTD0250 Transporter Info
Gene Name SLC29A4
Transporter Name Equilibrative nucleoside transporter 4
Gene ID
222962
UniProt ID
Q7RTT9
Post-Translational Modification of This DT
Overview of SLC29A4 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-N-glycosylation X-Phosphorylation X: Amino Acid

N-glycosylation

  Asparagine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC29A4 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

523

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC29A4 Asparagine 523 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          5 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC29A4 [2] , [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

207

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC29A4 Serine 207 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC29A4 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

214

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC29A4 Serine 214 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC29A4 [2] , [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

216

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC29A4 Serine 216 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC29A4 [5] , [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

306

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC29A4 Serine 306 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC29A4 [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

310

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC29A4 Serine 310 has the potential to affect its expression or activity.

  Threonine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC29A4 [3] , [7]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

199

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC29A4 Threonine 199 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC29A4 [2] , [3]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

204

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC29A4 Threonine 204 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC29A4 [2] , [3]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

208

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC29A4 Threonine 208 has the potential to affect its expression or activity.

  Tyrosine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC29A4 [3] , [7]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

198

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC29A4 Tyrosine 198 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC29A4 [8]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

322

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC29A4 Tyrosine 322 has the potential to affect its expression or activity.
References
1 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: S29A4_HUMAN)
2 Global phosphoproteomic analysis reveals ARMC10 as an AMPK substrate that regulates mitochondrial dynamics. Nat Commun. 2019 Jan 10;10(1):104.
3 TiO2 with Tandem Fractionation (TAFT): An Approach for Rapid, Deep, Reproducible, and High-Throughput Phosphoproteome Analysis. J Proteome Res. 2018 Jan 5;17(1):710-721.
4 FAIMS and Phosphoproteomics of Fibroblast Growth Factor Signaling: Enhanced Identification of Multiply Phosphorylated Peptides. J Proteome Res. 2015 Dec 4;14(12):5077-87.
5 Defeating Major Contaminants in Fe3+- Immobilized Metal Ion Affinity Chromatography (IMAC) Phosphopeptide Enrichment. Mol Cell Proteomics. 2018 May;17(5):1028-1034.
6 Temporal proteomics of NGF-TrkA signaling identifies an inhibitory role for the E3 ligase Cbl-b in neuroblastoma cell differentiation. Sci Signal. 2015 Apr 28;8(374):ra40.
7 Functional Proteomics Identifies Acinus L as a Direct Insulin- and Amino Acid-Dependent Mammalian Target of Rapamycin Complex 1 (mTORC1) Substrate. Mol Cell Proteomics. 2015 Aug;14(8):2042-55.
8 Ultra-deep tyrosine phosphoproteomics enabled by a phosphotyrosine superbinder. Nat Chem Biol. 2016 Nov;12(11):959-966.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.